Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2025-12-25 @ 12:04 AM
NCT ID:
NCT05278858
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with alopecia areata by either:
* A board-certified dermatologist, OR
* Dermatology Nurse Practitioner, OR
* Skin punch biopsy
* Patient has at least 2 alopecic patches each measuring at least 2 cm2 and are…
* Located on contralateral body sites OR
* Within the same body site but separated by ≥ 1 cm
* Patient is a candidate for intralesional triamcinolone.
* Patient able to give informed assent under IRB approval procedures when appropriate.
* At least one parent or guardian is able to provide informed consent.
Exclusion Criteria:
* Patient has alopecia totalis, alopecia universalis, or alopecia areata with ophiasis pattern.
* Known allergy or hypersensitivity to triamcinolone acetonide
* Pregnant, breastfeeding, or planning to get pregnant 4 weeks before, during, and 4 weeks after the study.
* Patient is unable/unwilling to provide informed assent when applicable.
* Known medical diagnosis or use of a medication that alters pain response at time of injection.
* Active infection at site designated for injection.
* If currently being treated for alopecia areata, the current treatment regimen has been started within less than 4 weeks of screening.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
17 Years
Study:
NCT05278858
Study Brief:
Protocol Section:
NCT05278858